Literature DB >> 26180096

Novel use of 4D-CTA in imaging of intranidal aneurysms in an acutely ruptured arteriovenous malformation: is this the way forward?

Arun Chandran1, Mark Radon1, Shubhabrata Biswas1, Kumar Das1, Mani Puthuran1, Hans Nahser1.   

Abstract

Ruptured arteriovenous malformation (AVM) is a frequent cause of intracranial hemorrhage. The presence of associated aneurysms, especially intranidal aneurysms, is considered to increase the risk of re-hemorrhage. We present two cases where an intranidal aneurysm was demonstrated on four-dimensional CT angiography (time-resolved CT angiography) (4D-CTA). These features were confirmed by digital subtraction angiography (catheter arterial angiogram). This is the first report of an intranidal aneurysm demonstrated by 4D-CTA. 4D-CTA can offer a comprehensive evaluation of the angioarchitecture and flow dynamics of an AVM for appropriate classification and management. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

Entities:  

Keywords:  Aneurysm; Angiography; Arteriovenous Malformation; CT Angiography; Hemorrhage

Mesh:

Year:  2015        PMID: 26180096     DOI: 10.1136/neurintsurg-2015-011784.rep

Source DB:  PubMed          Journal:  J Neurointerv Surg        ISSN: 1759-8478            Impact factor:   5.836


  2 in total

Review 1.  Targeted endovascular treatment for ruptured brain arteriovenous malformations.

Authors:  Kun Hou; Kan Xu; Xuan Chen; Tiefeng Ji; Yunbao Guo; Jinlu Yu
Journal:  Neurosurg Rev       Date:  2019-11-13       Impact factor: 3.042

2.  Comparative analysis of aneurysm volume by different methods based on angiography and computed tomography angiography.

Authors:  Víctor Hugo Escobar-de la Garma; Marco Zenteno; Felipe Padilla-Vázquez; Daniel San-Juan; Aurelio Cerón-Morales
Journal:  Neurosurg Rev       Date:  2018-01-16       Impact factor: 3.042

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.